Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-09T22:19:43.354Z Has data issue: false hasContentIssue false
  • English
  • Français

Increased plasma complement factor H is associated with geriatric depression

Published online by Cambridge University Press:  25 May 2018

Cheolmin Shin Open the ORCID record for Cheolmin Shin [Opens in a new window] ,
Byung-Joo Ham ,
Young-Hoon Ko ,
Chi-Un Pae ,
Moon Ho Park ,
David C. Steffens ,
Ashwin A. Patkar  and
Changsu Han
Cheolmin Shin
Affiliation:
Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea
Byung-Joo Ham
Affiliation:
Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea
Young-Hoon Ko
Affiliation:
Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea
Chi-Un Pae
Affiliation:
Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Moon Ho Park
Affiliation:
Department of Neurology, College of Medicine, Korea University, Seoul, Republic of Korea
David C. Steffens
Affiliation:
Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut, USA
Ashwin A. Patkar
Affiliation:
Department of Psychiatry and Behavioural Sciences, Duke University Medical Center, Durham, North Carolina, USA
Changsu Han*
Affiliation:
Department of Psychiatry, College of Medicine, Korea University, Seoul, Republic of Korea
*
Correspondence should be addressed to: Changsu Han, MD, PhD, MHS, Department of Psychiatry, College of Medicine, Korea University, Ansan Hospital, 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do 15355 Seoul, Republic of Korea. Phone: +82-31-4125140; Fax: +82-31-4125144. Email: hancs@korea.ac.kr.
Get access

Abstract

Background:

Complement factor H (CFH) plays a key role in regulating the cascade of the alternative pathway of the complement system. Dysregulation of CFH may be involved in the pathophysiology of various inflammation-mediated diseases including neuropsychiatric illnesses. This study aimed to investigate this relationship by examining determining CFH levels in elderly individuals with and without depression.

Methods:

A total of 152 elderly individuals (major depressive disorder (MDD) group, n = 76; comparison sample, n = 76) were selected from the Ansan Geriatric study. The plasma level of CFH was measured. MDD was diagnosed with the Mini-International Neuropsychiatric Interview as per DSM-IV criteria. The severity of depression was evaluated with the geriatric depression scale (GDS). Mean CFH levels were compared using the Mann–Whitney U test. After adjusting for possible confounding factors including age, sex, marital status, education, alcohol use, hemoglobin levels, and the Korean version of the Mini-Mental State Examination (MMSE-KC), a multiple regression analysis was conducted. The GDS score and plasma level of CFH were analyzed using Spearman's correlation.

Results:

Plasma CFH level was significantly higher in individuals with MDD than in the comparison sample (289.51 ± 21.16 vs. 339.67 ± 66.23, p < 0.001). In a regression model adjusted for possible confounders, CFH was significantly associated with geriatric depression (p < 0.001). CFH levels were not significantly related to GDS scores in the depressed group.

Conclusion:

This study revealed an association between high plasma levels of CFH and geriatric depression, thereby suggesting the alternative pathway of the complement system contributing to the development of geriatric depression.

Keywords

complement factor Hgeriatric depressioncomplement systemalternative pathway

Information

Type
Original Research Article
Information
International Psychogeriatrics , Volume 31 , Issue 1: Issue Theme: Parkinson's Disease , January 2019 , pp. 101 - 108
Copyright
Copyright © International Psychogeriatric Association 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Abdel Rasol, H. A., Helmy, H. and Aziz, M. A. (2015). Serum complement factor H and Tyr402 his gene polymorphism among Egyptians with multiple sclerosis. Neurological Research, 37, 845–852.Google Scholar
Bae, J. N. and Cho, M. J. (2004). Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. Journal of Psychosomatic Research, 57, 297–305.Google Scholar
Bremmer, M. A. et al. (2008). Inflammatory markers in late-life depression: results from a population-based study. Journal of Affective Disorders, 106, 249–255.Google Scholar
Bruunsgaard, H., Pedersen, M. and Pedersen, B. K. (2001). Aging and proinflammatory cytokines. Current Opinion on Hematology, 8, 131–136.Google Scholar
Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155–159.Google Scholar
de Cordoba, S. R., Tortajada, A., Harris, C. L. and Morgan, B. P. (2012). Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology, 217, 1034–1046.Google Scholar
Dilger, R. N. and Johnson, R. W. (2008). Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. Journal of Leukocyte Biology, 84, 932–939.Google Scholar
Gasque, P., Dean, Y. D., McGreal, E. P., VanBeek, J. and Morgan, B. P. (2000). Complement components of the innate immune system in health and disease in the CNS. Immunopharmacology, 49, 171–186.Google Scholar
Gruver, A. L., Hudson, L. L. and Sempowski, G. D. (2007). Immunosenescence of ageing. Journal of Pathology, 211, 144–156.Google Scholar
Hakobyan, S. et al. (2008). Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. Investigative Ophthalmology & Visual Science, 49, 1983–1990.Google Scholar
Hamilton, G. et al. (2007). Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease. Neuromolecular Medicine, 9, 331–334.Google Scholar
Han, C., Jo, S. A., Kim, N. H., Jo, I. and Park, M. H. (2009). Study design and methods of the Ansan Geriatric Study (AGE study). BMC Neurology, 9, 10.Google Scholar
Heese, K., Hock, C. and Otten, U. (1998). Inflammatory signals induce neurotrophin expression in human microglial cells. Journal of Neurochemistry, 70, 699–707.Google Scholar
Hye, A. et al. (2006). Proteome-based plasma biomarkers for Alzheimer's disease. Brain, 129, 3042–3050.Google Scholar
Ingram, G. et al. (2010). Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain, 133, 1602–1611.Google Scholar
Jung, I. K., Kwak, D. I., Shin, D. K., Lee, M. S., Lee, H. S. and Kim, J. Y. (1997). A reliability and validity study of geriatric depression scale. Journal of Korean Neuropsychiatric Association, 36, 103–112.Google Scholar
Kim, J., Park, M. H., Kim, E., Han, C., Jo, S. A. and Jo, I. (2007). Plasma homocysteine is associated with the risk of mild cognitive impairment in an elderly Korean population. Journal of Nutrition, 137, 2093–2097.Google Scholar
Kopp, A., Hebecker, M., Svobodova, E. and Jozsi, M. (2012). Factor H: a complement regulator in health and disease, and a mediator of cellular interactions. Biomolecules, 2, 46–75.Google Scholar
Lee, J. H. et al. (2002). Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. Journals of Gerontology B: Psychological Sciences and Social Sciences, 57, P47–53.Google Scholar
Liszewski, M. K., Farries, T. C., Lublin, D. M., Rooney, I. A. and Atkinson, J. P. (1996). Control of the complement system. Advances in Immunology, 61, 201–283.Google Scholar
Meyers, B. S. (1998). Depression and dementia: comorbidities, identification, and treatment. Journal of Geriatric Psychiatry and Neurology, 11, 201–205.Google Scholar
Muller-Eberhard, H. J. (1988). Molecular organization and function of the complement system. Annual Review of Biochemistry, 57, 321–347.Google Scholar
Oksjoki, R., Jarva, H., Kovanen, P. T., Laine, P., Meri, S. and Pentikainen, M. O. (2003). Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arteriosclerosis Thrombosis and Vascular Biology, 23, 630–636.Google Scholar
Rodriguez de Cordoba, S., Esparza-Gordillo, J., Goicoechea de Jorge, E., Lopez-Trascasa, M. and Sanchez-Corral, P. (2004). The human complement factor H: functional roles, genetic variations and disease associations. Molecular Immunology, 41, 355–367.Google Scholar
Scholl, H. P. et al. (2008). Systemic complement activation in age-related macular degeneration. PLoS One, 3, e2593.Google Scholar
Shinjyo, N., Stahlberg, A., Dragunow, M., Pekny, M. and Pekna, M. (2009). Complement-derived anaphylatoxin C3a regulates in vitro differentiation and migration of neural progenitor cells. Stem Cells, 27, 2824–2832.Google Scholar
Stevens, B. et al. (2007). The classical complement cascade mediates CNS synapse elimination. Cell, 131, 1164–1178.Google Scholar
Thomas, A. J., Davis, S., Morris, C., Jackson, E., Harrison, R. and O'Brien, J. T. (2005). Increase in interleukin-1beta in late-life depression. American Journal of Psychiatry, 162, 175–177.Google Scholar
Weiszhar, Z. et al. (2013). Elevated complement factor H levels in asthmatic sputa. Journal of Clinical Immunology, 33, 496–505.Google Scholar
Yanamadala, V. and Friedlander, R. M. (2010). Complement in neuroprotection and neurodegeneration. Trends in Molecular Medicine, 16, 69–76.Google Scholar
Yoo, S.-W. et al. (2006). Validity of Korean version of the Mini-International Neuropsychiatric Interview. Anxiety and Mood, 2, 50–55.Google Scholar
Zhang, C. et al. (2016). Complement factor H and susceptibility to major depressive disorder in Han Chinese. British Journal of Psychiatry, 208, 446–452.Google Scholar
Zipfel, P. F., Jokiranta, T. S., Hellwage, J., Koistinen, V. and Meri, S. (1999). The factor H protein family. Immunopharmacology, 42, 53–60.Google Scholar